Back to Results
First PageMeta Content
Clinical research / Toxicology / Critical Path Institute / Pre-clinical development / Food and Drug Administration / Drug development / Biomarker / Rofecoxib / Adverse effect / Pharmacology / Pharmaceutical sciences / Medicine


Translational Safety in Drug Development – Innovations and Challenges A Joint Regional Chapter Meeting with SCCSOT and the Critical Path Institute Accelerating the Path to a Healthier World
Add to Reading List

Document Date: 2015-03-05 12:14:42

Open Document

File Size: 1,41 MB

Share Result on Facebook

City

Tucson / /

Country

United States / /

Facility

USA The Critical Path Institute / Critical Path Institute / /

MedicalCondition

rofecoxib inflammatory pain H1 receptor blocking / Side Effect/Toxicity Action HMG-CoA reductase rhabdomyolysis / agonist astemizole allergy / dysfunction / cardiovascular disease troglitazone diabetes PPAR / /

Organization

Critical Path Institute / Food and Drug Administration / Joint Regional Chapter / /

Person

Predictive Safety Testing / John-Michael Sauer / /

Position

Executive Director / /

ProvinceOrState

Arizona / /

Technology

drug discovery / Drug Development / /

SocialTag